Seth Klarman - Baupost Group
Holding/activity history for Finch Therapeutics Group Inc (FNCHQ)
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Reported Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2024 Q1 | 0 | 0.00 | Sell 100.00% | 0.01 | SEC | ||
| 2023 Q4 | 67,296 | 0.01 | $3.61 | $243,000 | SEC | ||
| 2023 Q3 | 67,296 | 0.01 | $5.19 | $349,000 | SEC | ||
| 2023 Q2 | 67,296 | 0.01 | Reduce 96.67% | <0.01 | $8.53 | $574,000 | SEC |
| 2023 Q1 | 2,019,008 | 0.01 | Add 98.13% | <0.01 | $0.39 | $793,000 | SEC |
| 2022 Q4 | 1,019,008 | 0.01 | Reduce 9.27% | <0.01 | $0.48 | $489,000 | SEC |
| 2022 Q3 | 1,123,108 | 0.03 | $1.67 | $1,876,000 | SEC | ||
| 2022 Q2 | 1,123,108 | 0.05 | $2.84 | $3,190,000 | SEC | ||
| 2022 Q1 | 1,123,108 | 0.06 | Reduce 0.81% | <0.01 | $5.03 | $5,649,000 | SEC |
| 2021 Q4 | 1,132,253 | 0.12 | Reduce 6.28% | <0.01 | $9.97 | $11,289,000 | SEC |
| 2021 Q3 | 1,208,159 | 0.15 | $13.00 | $15,706,000 | SEC | ||
| 2021 Q2 | 1,208,159 | 0.14 | $13.82 | $16,693,000 | SEC | ||
| 2021 Q1 | 1,208,159 | 0.15 | Buy | 0.15 | $15.62 | $18,870,000 | SEC |